BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30877466)

  • 21. Association of qualitative and quantitative imaging features on multiphasic multidetector CT with tumor grade in clear cell renal cell carcinoma.
    Coy H; Young JR; Douek ML; Pantuck A; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2019 Jan; 44(1):180-189. PubMed ID: 29987358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of an individualized DNA repair-related gene signature in localized clear cell renal cell carcinoma.
    Xiong Y; Qi Y; Lin W; Bai Q; Liu L; Guo J
    World J Urol; 2021 Apr; 39(4):1203-1210. PubMed ID: 32458095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiogenomic analysis based on lipid metabolism-related subset for non-invasive prediction for prognosis of renal clear cell carcinoma.
    He H; Xie Y; Song F; Feng Z; Rong P
    Eur J Radiol; 2024 Jun; 175():111433. PubMed ID: 38554673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clear cell renal cell carcinoma: CT-based radiomics features for the prediction of Fuhrman grade.
    Shu J; Tang Y; Cui J; Yang R; Meng X; Cai Z; Zhang J; Xu W; Wen D; Yin H
    Eur J Radiol; 2018 Dec; 109():8-12. PubMed ID: 30527316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT-Based Radiomics Signature for Preoperative Prediction of Coagulative Necrosis in Clear Cell Renal Cell Carcinoma.
    Xu K; Liu L; Li W; Sun X; Shen T; Pan F; Jiang Y; Guo Y; Ding L; Zhang M
    Korean J Radiol; 2020 Jun; 21(6):670-683. PubMed ID: 32410406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma.
    Wang ZR; Wei JH; Zhou JC; Haddad A; Zhao LY; Kapur P; Wu KJ; Wang B; Yu YH; Liao B; He DL; Chen W; Margulis V; Hsieh JT; Luo JH
    Oncotarget; 2016 May; 7(21):31508-19. PubMed ID: 27129174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
    Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
    Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma.
    Demirjian NL; Varghese BA; Cen SY; Hwang DH; Aron M; Siddiqui I; Fields BKK; Lei X; Yap FY; Rivas M; Reddy SS; Zahoor H; Liu DH; Desai M; Rhie SK; Gill IS; Duddalwar V
    Eur Radiol; 2022 Apr; 32(4):2552-2563. PubMed ID: 34757449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival.
    Zhao J; Lu L
    Recent Pat Anticancer Drug Discov; 2021; 16(3):363-376. PubMed ID: 33563180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collateral vessels on preoperative enhanced computed tomography for predicting pathological grade of clear cell renal cell carcinoma: A retrospective study.
    Shi Y; Ni L; Pei J; Zhan H; Li H; Zhang D; Wang L
    Eur J Radiol; 2024 Jan; 170():111240. PubMed ID: 38043383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell Carcinoma.
    Zhang D; Wang Y; Hu X
    DNA Cell Biol; 2020 Oct; 39(10):1799-1812. PubMed ID: 32716214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging Tool for Predicting Renal Clear Cell Carcinoma Fuhrman Grade: Comparing R.E.N.A.L. Nephrometry Score and CT Texture Analysis.
    Sun R; Zhao S; Jiang H; Jiang H; Dai Y; Zhang C; Wang S
    Biomed Res Int; 2021; 2021():1821876. PubMed ID: 34977234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
    Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of dual energy spectral CT and pathological grading of clear cell renal cell carcinoma (ccRCC).
    Wei J; Zhao J; Zhang X; Wang D; Zhang W; Wang Z; Zhou J
    PLoS One; 2018; 13(5):e0195699. PubMed ID: 29715308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [RUNX3 promoter hypermethylation and prognosis of early surgically resected non-small cell lung cancers].
    Tang Y; Wu F; Hu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):650-4. PubMed ID: 21873791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
    Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
    Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of tumor grade, enhancement on multiphasic CT and microvessel density in patients with clear cell renal cell carcinoma.
    Coy H; Young JR; Pantuck AJ; Douek ML; Sisk A; Magyar C; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2020 Oct; 45(10):3184-3192. PubMed ID: 31650375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.